IL1B and myeloid sarcoma: It has been emphasized that SPX reduces IL-1β and TNF-α levels by inhibiting inflammation together with the activation of PAR-ɣ and AMPK in type-2 DM and MS, and with this effect, it can be used in the treatment.[22,23]